Michael T. Constantino is Director of Humacyte, Inc.. Currently has a direct ownership of 16,950 shares of HUMA, which is worth approximately $89,665. The most recent transaction as insider was on Dec 04, 2024, when has been sold 4,600 shares (Common Stock) at a price of $4.39 per share, resulting in proceeds of $20,194. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17K
37.25% 3M change
83.24% 12M change
Total Value Held $89,665

Michael T. Constantino Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2024
BUY
Open market or private purchase
$20,194 $4.39 p/Share
4,600 Added 21.35%
16,950 Common Stock
Aug 15 2024
BUY
Open market or private purchase
$19,499 $6.29 p/Share
3,100 Added 20.06%
12,350 Common Stock
May 18 2023
BUY
Open market or private purchase
$19,855 $4.18 p/Share
4,750 Added 33.93%
9,250 Common Stock
May 23 2022
BUY
Open market or private purchase
$9,660 $4.83 p/Share
2,000 Added 30.77%
4,500 Common Stock
Nov 22 2021
BUY
Open market or private purchase
$27,025 $10.81 p/Share
2,500 Added 50.0%
2,500 Common Stock

Also insider at

NMTR
9 METERS BIOPHARMA, INC. Healthcare
MTC

Michael T. Constantino

Director
Raleigh, NC

Track Institutional and Insider Activities on HUMA

Follow Humacyte, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HUMA shares.

Notify only if

Insider Trading

Get notified when an Humacyte, Inc. insider buys or sells HUMA shares.

Notify only if

News

Receive news related to Humacyte, Inc.

Track Activities on HUMA